cdmo.directory
← Compare landing

Altasciences vs Eurofins Central Laboratory

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/altasciences/eurofins

CategoryAltasciencesEurofins Central Laboratory
Listed sitebothboth
SummaryMid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.Global network of over 950 laboratories across 57 countries offering comprehensive contract research, testing, and manufacturing services including BioPharma discovery, bioanalysis, Phase I clinics, CDMO, central laboratory services, and specialized analytical testing.
Services
  • Preclinical In Vivo Studies
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro Pharmacology
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Clinical Trial Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Medical Writing
  • Clinical Operations
  • Regulatory Affairs
  • In Vivo PK / PD Studies
  • Preclinical In Vitro Studies
  • Phase IV / Post-Marketing
  • In Vitro ADME / DMPK
  • Formulation Development
  • Stability Testing & Storage
  • Central Laboratory Services
  • Phase I Clinical Trials
  • Bioanalysis
  • Genomics & Sequencing Services
  • Translational Research
  • Analytical Method Development & Validation
  • ICH Stability Studies
Modalities
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
Data not yet provided.
Indications
  • Cardiovascular
  • Dermatology
  • Gastroenterology
  • Immunology
  • Infectious Disease
  • Metabolic
  • Neurology
  • Oncology
  • Ophthalmology
  • Psychiatry
  • Respiratory
  • Women's Health
Data not yet provided.
Locations
  • Headquarters, Montreal, Quebec, Canada
  • Bioanalytical Laboratory, Laval, Quebec, Canada
  • Clinical Site, Montreal, Quebec, Canada
  • Clinical and Research Campus, Overland Park, Kansas, United States
  • Preclinical Testing, Everett, Washington, United States
  • Manufacturing and Analytical Services, Harleysville, Pennsylvania, United States
  • Preclinical Testing, Scranton, Pennsylvania, United States
  • Preclinical Testing, Columbia, Missouri, United States
  • Clinical Pharmacology, Cypress, California, United States
  • Preclinical Testing, Sacramento, California, United States
  • Laval, Laval, Quebec, Canada
  • Overland Park, Overland Park, Kansas, United States
  • Everett, Everett, Washington, United States
  • Harleysville, Harleysville, Pennsylvania, United States
  • Cypress, Cypress, California, United States
  • Scott Township, Scott Township, Pennsylvania, United States
  • Auxvasse, Auxvasse, Missouri, United States
  • Sacramento, Sacramento, California, United States
  • Canada, Canada, Canada
  • United States, United States, United States
  • Canada and U.S. operations
  • Headquarters
Certifications
  • FDA · Identifier: FDA inspection passed 2001
  • GLP · Identifier: GLP Compliant
  • GMP · Identifier: GMP Manufacturing
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.